+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Extracorporeal Shock Wave Lithotripsy Market: By Technique, By Application, By End-User & By Region - Forecast 2016-2021

  • ID: 3973766
  • Report
  • 138 pages
  • IndustryARC
1 of 2
Extracorporeal shock wave lithotripsy (ESWL) is a common non-invasive treatment for kidney stones and ureter stones. The lithotriptor applies external high-intensity acoustic pulse to crush the stone causing minimal damage to the normal tissue. The shock waves break the stones into small fragments. ESWL is currently used by physician worldwide due to characteristics such as non-invasiveness, reduced pain and recovery time and reduced hospital stay. With advancements in health care infrastructure by and availability of technically developed equipment to carry out the procedure are the vital drivers for the extracorporeal shock wave lithotripsy market. Moreover, the rising prevalence and incidences of kidney stones and ureter stones are expected to fuel the extracorporeal shock wave lithotripsy market in near future. Additionally, the rising prevalence of obesity and patient awareness about the latest technological advancements will be a prime factor that will be contributing to the growth of the market. However, failure of crushing large stones through ESWL is the challenging factor for the extracorporeal shock wave lithotripsy market.

This report identifies the global extracorporeal shock wave lithotripsy market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to extracorporeal shock wave lithotripsy market.

Geographically North America dominated global extracorporeal shock wave lithotripsy market, and Asia Pacific is projected to have fastest growth, owing to significant investment in medical device, technology research and development, improvisation of the infrastructure, favourable insurance policies, and rising lifestyle changes in this region
This report segments global extracorporeal shock wave lithotripsy market on the basis of technique, by application, by end user and by region are as follows:

Extracorporeal Shock Wave Lithotripsy Market, by Technique: Electrohydraulic, Electromagnetic, and Piezoelectric
Extracorporeal Shock Wave Lithotripsy Market, by Application: Kidney Stones, Uretic Stones, Pancreatic Stones, and Salivary Stones
Extracorporeal Shock Wave Lithotripsy Market, by End-User: Hospitals, Clinics, Radiology labs, and Others
This is report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the Extracorporeal Shock Wave Lithotripsy market. Some of the major companies’ profiles in detail are as follows:

Boston Scientific Corporation
C.R. Bard Inc.

Lumenis LTD
GE Healthcare
Siemens AG
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
Note: Product cover images may vary from those shown
2 of 2
1. Extracorporeal Shock Wave Lithotripsy – Market Overview

2. Executive Summary

3. Extracorporeal Shock Wave Lithotripsy Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis

4. Extracorporeal Shock Wave Lithotripsy – Market Forces
4.1. Drivers
4.1.1. Increasing prevalence of obesity
4.1.2. Rising population and changing lifestyle
4.2. Restraints
4.2.1. High cost of technology
4.3. Opportunities
4.3.1. Emerging economies
4.4. Challenges
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition

5. Extracorporeal Shock Wave Lithotripsy Market- By Technique
5.1. Electrohydraulic
5.2. Electromagnetic
5.3. Piezoelectric

6. Extracorporeal Shock Wave Lithotripsy Market- By Application
6.1. Introduction
6.2. kidney Stones
6.3. Uretic Stones
6.4. Pancreatic Stones
6.5. Salivary Stones

7. Extracorporeal Shock Wave Lithotripsy Market- By End-User
7.1. Hospitals
7.2. Clinics
7.3. Radiology labs
7.4. others

8. Global Extracorporeal Shock Wave Lithotripsy Market- By Geography (2014-2021)
8.1. Europe
8.1.1. Germany
8.1.2. France
8.1.3. Italy
8.1.4. Spain
8.1.5. Russia
8.1.6. U.K.
8.1.7. Rest of Europe
8.2. Asia Pacific
8.2.1. China
8.2.2. India
8.2.3. Japan
8.2.4. South Korea
8.2.5. Rest of Asia-Pacific
8.3. North America
8.3.1. U.S.
8.3.2. Canada
8.3.3. Mexico
8.4. Rest of the World (RoW)
8.4.1. Brazil
8.4.2. Rest of RoW

9. Extracorporeal Shock Wave Lithotripsy – Market Entropy
9.1. Expansion
9.2. Technological Developments
9.3. Merger & Acquisitions, and Joint Ventures
9.4. Supply- Contract

10. Company Profiles (Top 10 Companies)
10.1. Boston Scientific Corporation
10.1.1. Introduction
10.1.2. Financials
10.1.3. Key Insights
10.1.4. Key Strategy
10.1.5. Product Portfolio
10.1.6. SWOT Analysis
10.2. C.R. Bard Inc.
10.2.1. Introduction
10.2.2. Financials
10.2.3. Key Insights
10.2.4. Key Strategy
10.2.5. Product Portfolio
10.2.6. SWOT Analysis
10.3. Lumenis LTD
10.3.1. Introduction
10.3.2. Financials
10.3.3. Key Insights
10.3.4. Key Strategy
10.3.5. Product Portfolio
10.3.6. SWOT Analysis
10.4. GE Healthcare
10.4.1. Introduction
10.4.2. Financials
10.4.3. Key Insights
10.4.4. Key Strategy
10.4.5. Product Portfolio
10.4.6. SWOT Analysis
10.5. Siemens AG
10.5.1. Introduction
10.5.2. Financials
10.5.3. Key Insights
10.5.4. Key Strategy
10.5.5. Product Portfolio
10.5.6. SWOT Analysis
10.6. Medtrue Enterprise Co. Ltd.
10.6.1. Introduction
10.6.2. Financials
10.6.3. Key Insights
10.6.4. Key Strategy
10.6.5. Product Portfolio
10.6.6. SWOT Analysis
10.7. Karl Storz Gmbh and Co. KG
10.7.1. Introduction
10.7.2. Financials
10.7.3. Key Insights
10.7.4. Key Strategy
10.7.5. Product Portfolio
10.7.6. SWOT Analysis
10.8. Olympus Corporation
10.8.1. Introduction
10.8.2. Financials
10.8.3. Key Insights
10.8.4. Key Strategy
10.8.5. Product Portfolio
10.8.6. SWOT Analysis
10.9. Sainty Pharma
10.9.1. Introduction
10.9.2. Financials
10.9.3. Key Insights
10.9.4. Key Strategy
10.9.5. Product Portfolio
10.9.6. SWOT Analysis
10.10. Dornier MedTech GmbH
10.10.1. Introduction
10.10.2. Financials
10.10.3. Key Insights
10.10.4. Key Strategy
10.10.5. Product Portfolio
10.10.6. SWOT Analysis
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

11. Appendix
11.1. Abbreviations
11.2. Sources
11.3. Research Methodology
11.4. Expert Insights
Note: Product cover images may vary from those shown
3 of 2